Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • HATU: Mechanism and Evidence Boundaries

    2026-10-19

    HATU is widely recognized by its acronym and by the chemical name 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate. APExBIO lists it as product A7022 and describes it as a peptide coupling reagent for carboxylic acid activation and subsequent amide or ester formation. The relevant HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) page is the principal evidence source available here.

    1. Documented identity and scientific context

    On the basis of the product description, HATU is a small-molecule coupling reagent intended for synthetic chemistry applications, particularly peptide synthesis chemistry and other contexts involving amide bond formation. APExBIO reports a molecular weight of 380.2 and a typical purity of approximately 98%. These details document how the supplier identifies and characterizes the catalog product; they do not independently establish analytical identity, batch-to-batch consistency, or performance in a particular reaction system.

    The product description places HATU within a class of reagents used to promote bond formation between a carboxylic acid and a nucleophilic partner. The named application areas include peptide synthesis, amide and ester formation, and biochemical or pharmaceutical research. Those categories define an intended scientific scope rather than a demonstrated performance envelope. In particular, the description does not establish that every peptide sequence, protecting-group pattern, functional-group combination, or scale will behave similarly.

    2. Documented mechanism and measurement principle

    APExBIO describes the mechanism as carboxylic acid activation through formation of a reactive OAt-active ester. In conceptual terms, the carboxyl group is converted into a more electrophilic intermediate, after which a nucleophile such as an amine or alcohol can participate in bond formation. An amine partner corresponds conceptually to amide formation, while an alcohol partner corresponds to ester formation.

    This distinction between an upstream chemical event and a downstream readout is important. Formation of an activated intermediate is a mechanistic claim; detection or isolation of an amide or ester is an outcome claim. A measured product signal, conversion value, or isolated yield would establish that a downstream transformation was observed under the studied conditions, but it would not by itself prove the detailed sequence or lifetime of every intermediate. Conversely, the supplier's mechanistic description explains the proposed reaction pathway but supplies no kinetic measurements, intermediate characterization, substrate panel, or quantitative comparison with alternative reagents.

    The product description also mentions a common association with Hünig's base, or DIPEA. That association supports the phrase peptide coupling with DIPEA as a description of a reported reagent pairing, but it does not show that DIPEA is required, optimal, or superior to other bases. No comparative evidence for that pairing is provided.

    3. Interpretation of the reported properties and scope

    Claim What the product information reports Proportionate interpretation
    Identity HATU, product A7022, molecular weight 380.2, and typical purity near 98%. These are catalog-level identity and specification details, not independent structural or analytical verification.
    Mechanism Carboxylic acids are described as being converted into OAt-active esters that can react with amines or alcohols. This supports a conceptual activation mechanism for amide and ester formation, but no kinetic or intermediate-level research evidence is supplied.
    Application scope Peptide synthesis, amide bond formation, esterification, and biochemical or pharmaceutical research are named. The description indicates intended use categories; it does not establish universal substrate compatibility or comparative efficiency.
    Physical behavior The page reports limited solubility in water and ethanol and compatibility with DMSO at the stated product specification. These are supplier-reported physical properties and should not be interpreted as evidence of reaction performance, stability across formulations, or suitability for a particular assay.

    The supplier uses efficiency-oriented language, including descriptions of rapid or high-yield coupling. No numerical yields, sample sizes, uncertainty estimates, substrate-by-substrate results, or defined comparator data accompany those claims in the available material. Accordingly, they should be treated as product-description assertions rather than as quantified research findings.

    4. Evidence availability and specific boundaries

    No identity-matched research paper or primary dataset is available for evaluating HATU A7022 in a defined experimental system. The evidence therefore supports a documented identity and a supplier-attributed mechanistic rationale, but not an independent assessment of performance. There are no supplied data establishing reaction rates, conversion distributions, selectivity, reproducibility, impurity profiles, or differences between HATU and other coupling reagents.

    Several boundaries follow directly from that absence of matched evidence:

    • The product description does not establish how performance varies across peptide sequences, sterically hindered substrates, sensitive functional groups, or non-peptide substrates.
    • It does not quantify the relative contribution of carboxylic acid activation, nucleophile reactivity, base choice, solvent effects, or competing pathways to an observed outcome.
    • It does not show whether a reported amide or ester product was assessed by a particular analytical method, nor does it provide uncertainty or replicate information.
    • It does not support claims about biological activity, pharmaceutical efficacy, clinical utility, or compatibility with a biological assay merely because the reagent is marketed for biochemical or pharmaceutical research.
    • It does not permit a direct comparison with alternative peptide coupling reagents or with other base systems. Mentioning DIPEA describes a stated pairing, not a controlled comparator.

    These limitations also constrain interpretation of the term “highly efficient.” Efficiency could refer to reaction speed, isolated yield, conversion, reduced by-product formation, or a supplier's general application experience. Without a defined endpoint and comparator, the term has no single quantitative meaning.

    5. Concise factual synthesis

    HATU is documented by APExBIO as a peptide coupling reagent whose proposed role is to activate carboxylic acids through an OAt-active ester pathway, enabling subsequent amide or ester formation with suitable nucleophiles. Its catalog identity, reported molecular weight, approximate purity, and stated application areas support a product and mechanism overview. They do not constitute identity-matched primary research.

    For researchers, the central evidence distinction is between mechanistic plausibility and demonstrated performance. The former is supported here by the supplier's description of carboxylic acid activation; the latter would require substrate-defined data, explicit readouts, comparators, and uncertainty reporting, none of which are available in the present evidence base. The defensible conclusion is therefore limited: HATU is presented as a reagent for carboxylic acid activation in peptide synthesis chemistry and related amide and ester formation, while claims about quantitative efficiency, generality, or superiority remain unsubstantiated by the supplied identity-matched evidence.